Celera s Q1 Net Losses Up but Beat the Street by 17 Cents | GenomeWeb

NEW YORK, Oct 26 – Celera blew past analysts’ expectations on Thursday, with first-quarter fiscal 2001 results that beat the street’s estimate by 17 cents a share.

In the company's first fiscal quarter it reported a net loss of $25.7, or 43 cents a share, compared with a net loss of $19.4 million, or 38 cents a share, in the same period a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.